Product Information
METFORMIN HCL ER 750 MG TABLET is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.0526 per EA under NDC 76385012950. Its NADAC has been published 82 times since Mar 12, 2025.
FDA first approved this application on Dec 13, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
76385012950
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207427FDA Approved
12/13/2016
TE Code
AB1
On Market Since
6/28/2018
Pharmacological Classes
Price Statistics
The NADAC for METFORMIN HCL ER 750 MG TABLET has been published 82 times since Mar 12, 2025, and over the history we have for it it has declined 6.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0526 per EA |
|---|---|
| All-time high | $0.0566 (Feb 11, 2026) |
| All-time low | $0.0526 (Sep 17, 2025) |
| 52-week high | $0.0566 |
| 52-week low | $0.0526 |
| Median price | $0.0548 |
| Average price | $0.0549 |
| Largest weekly change | -3.2% (Apr 23, 2025) |
| Weeks tracked | 82 |
| Tracking since | Mar 12, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Unichem Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metformin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Biguanide class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METFORMIN HCL ER 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METFORMIN HCL ER 750 MG TABLET, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.0526 per EA (NDC 76385012950), effective Sep 30, 2026.
How has the price of METFORMIN HCL ER 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for METFORMIN HCL ER 750 MG TABLET has declined 6.6%. It has been tracked across 82 weekly CMS publications since Mar 12, 2025.
What are the highest and lowest recorded NADAC prices for METFORMIN HCL ER 750 MG TABLET?
Since Mar 12, 2025, the NADAC for METFORMIN HCL ER 750 MG TABLET has ranged from a low of $0.0526 (Sep 17, 2025) to a high of $0.0566 (Feb 11, 2026), with a median of $0.0548 per EA.
Are there cheaper alternatives to METFORMIN HCL ER 750 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METFORMIN HCL ER 750 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METFORMIN HCL ER 750 MG TABLET?
METFORMIN HCL ER 750 MG TABLET (NDC 76385012950) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.